Close
Close
Treatment Database
small molecule inhibitor of KRASG12C (Kirsten rat sarcoma viral oncogene homolog) mutant protein
Trade Name not avaiable
Orphan Indication KRAS p.G12C-positive non-small cell lung cancer
USA Market Approval
USA Designation Date 01-05-2019
Sponsor Amgen Inc.
1 Amgen Center Drive, Mail Stop 27-3-A
Thousand Oaks, California, 91320
More about Non-small cell lung cancer
Free Newsletter
Treatment News
Related Videos
by Abidemi Uruejoma
561 views
by Abidemi Uruejoma
4,167 views
by Abidemi Uruejoma
9,926 views
by Dr. Jules Richard Kemadjou
10,126 views